Row 47783

Row ID: 47783 | Dataset Entry | Axioma AXP Content Repository

Content Data

This page contains data entry 47783 from the Axioma AXP content repository. The structured data below represents the complete record for this entry.

The first 25m doses of their adjuvanted Malaria vaccine shipped too. There should be 100m doses per year. If Sanofi wants to use their adjuvant for any vaccines they will pay 200m in upfront and milestone payments and then royalties on sales. Sanofi have 77 clinical trial candidates so they must have a few in mind. It would be surprising if other pharmas are not also looking at it after the first 1.4bn deal with Sanofi. GSK, Merck etc could all have use for the adjuvant.

FieldValue
text The first 25m doses of their adjuvanted Malaria vaccine shipped too. There should be 100m doses per year. If Sanofi wants to use their adjuvant for any vaccines they will pay 200m in upfront and milestone payments and then royalties on sales. Sanofi have 77 clinical trial candidates so they must have a few in mind. It would be surprising if other pharmas are not also looking at it after the first 1.4bn deal with Sanofi. GSK, Merck etc could all have use for the adjuvant.
label r/wallstreetbets
dataType comment
communityName r/wallstreetbets
datetime 2024-05-22
username_encoded Z0FBQUFBQm5Lak1RZ0tybjVkZGxrRU1UM0FiaHF0OGU2SDF6Wk5hc0ptdkRuM0lTejV2YktadnEtWjU5dE9Xem9ZRGVtTFFqNEh2aXlJZmpwZjA5STV6WHd2UkVyTWNKcTVTdjg3b2ROQWI2ckgtYXN4LTllWDQ9
url_encoded Z0FBQUFBQm5Lak9nU0JfQXdrSFBiMHpuQjZRcHJyQ0tlRHQ1YzVlZ2EyVGo3cURvbHZxRTYxaFJ2SjVtNVpFelRoU00zaXlPSTBwZmJtTVBtc0dJMFJSbVdVQWNSdmkzeWoxNXVqN2Z6SjZaYkVFNHN5eHczc0pZVUE3TFREalYzZFJPZ29QOEJFOHIyNnNjSWJwVVVYUFVoM3l0UkZobjVRRFU3czJlOHlfZ0Q1bWR6Ykxmenp0eE1VN3dobWotbldtb1YzTEZQeXItQUF5UWNEcUh5UklrMVhYZzFYV1NsZz09

Raw Record

{
  "text": "The first 25m doses of their adjuvanted Malaria vaccine shipped too. There should be 100m doses per year. If Sanofi wants to use their adjuvant for any vaccines they will pay 200m in upfront and milestone payments and then royalties on sales. Sanofi have 77 clinical trial candidates so they must have a few in mind. It would be surprising if other pharmas are not also looking at it after the first 1.4bn deal with Sanofi. GSK, Merck etc could all have use for the adjuvant.",
  "label": "r/wallstreetbets",
  "dataType": "comment",
  "communityName": "r/wallstreetbets",
  "datetime": "2024-05-22",
  "username_encoded": "Z0FBQUFBQm5Lak1RZ0tybjVkZGxrRU1UM0FiaHF0OGU2SDF6Wk5hc0ptdkRuM0lTejV2YktadnEtWjU5dE9Xem9ZRGVtTFFqNEh2aXlJZmpwZjA5STV6WHd2UkVyTWNKcTVTdjg3b2ROQWI2ckgtYXN4LTllWDQ9",
  "url_encoded": "Z0FBQUFBQm5Lak9nU0JfQXdrSFBiMHpuQjZRcHJyQ0tlRHQ1YzVlZ2EyVGo3cURvbHZxRTYxaFJ2SjVtNVpFelRoU00zaXlPSTBwZmJtTVBtc0dJMFJSbVdVQWNSdmkzeWoxNXVqN2Z6SjZaYkVFNHN5eHczc0pZVUE3TFREalYzZFJPZ29QOEJFOHIyNnNjSWJwVVVYUFVoM3l0UkZobjVRRFU3czJlOHlfZ0Q1bWR6Ykxmenp0eE1VN3dobWotbldtb1YzTEZQeXItQUF5UWNEcUh5UklrMVhYZzFYV1NsZz09"
}
Explore Dataset Explore Row

Entry Information